Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
Similar Companies1000
OncoMyx Therapeutics
OncoMyx Therapeutics is a company that develops oncolytic immunotherapies using a unique virus called myxoma to treat cancer.
Sector
Subsector
Keywords
Location
total rounds
total raised
Abalos Therapeutics
Abalos Therapeutics is a company developing a novel immuno-virotherapy to fight cancer.
Sector
Subsector
Keywords
Location
total rounds
total raised
Immugenia
Immugenia is an immuno-oncology company developing a novel approach to CAR therapy.
Sector
Subsector
Location
total rounds
Oncolinx
Oncolinx is developing antibody-drug conjugates that target cancer cells without harming healthy cells.
Sector
Subsector
Keywords
Location
total rounds
total raised
Financials
Funding Rounds2
Number of Funding Rounds
Money Raised
Their latest funding was raised on 08.12.2021. Their latest investor Madison Partners. Their latest round Series B
B Capital Group
B Capital Group is a venture capital firm that invests in global entrepreneurs in the field of information technology.
Sector
Subsector
Location
count Of Investments
count Of Exists
Lumira Ventures
Lumira Ventures is a leading North American healthcare and life sciences venture capital firm.
Sector
Subsector
Location
count Of Investments
count Of Exists
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund invests in therapeutic biotechnology companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors9
Number of lead investors
Number of investors
Madison Partners
Madison Partners is a leading commercial real estate brokerage in Los Angeles.
Sector
Subsector
Location
count Of Investments
Korea Investment Partners
Korea Investment Partners: Leading venture capital & private equity firm with 30+ years experience.
Sector
Subsector
Location
count Of Investments
count Of Exists
B Capital Group
B Capital Group is a venture capital firm that invests in global entrepreneurs in the field of information technology.
Sector
Subsector
Location
count Of Investments
count Of Exists
Widya Mulyasasmita
Widya Mulyasasmita, Sr. Principal, Healthcare at B Capital Group.
People
Founders3
Steve Potts
Steve Potts, PhD, MBA (Founder & CEO) leads OncoMyx. Steve has worked in the biopharma industry since 1999 and has had experience in a wide range of areas, including product development, sales, marketing, and general management. He has a proven track record of success, with his last three companies all with significant shareholder returns. He was Vice President of Medical Affairs at Ignyta, which was acquired by Roche for $1.7B, and he led the global operation of the testing of 30,000 patients in an oncology basket trial for entrectinib in 15 countries. The molecule was the first in industry to receive breakthrough designation equivalents in USA, Europe, and Japan. Prior to Ignyta, he bootstrapped his first company as founding CEO, Flagship Biosciences, to 75 employees and an exit for his investors. He was General Manager Life Sciences at Aperio, which exited to Danaher for $180M. He also built the Bioinformatics Department for a Fortune 500 Company, Quest Diagnostics, which subsequently delivered $1B of annual revenue. He earned a BS in Physics from Wheaton College, Illinois and PhD in Biological Engineering and MBA from the University of California Davis.
current job
organization founded
Steve Potts
Gil Marmol
Guillermo G Marmol is the Chief Executive Officer at Viron Therapeutics. Guillermo attended Harvard Business School.
current job
Gil Marmol
